Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetic medicine 2021-01, Vol.38 (1), p.e14378-n/a
Hauptverfasser:	Rayman, G., Lumb, A. N., Kennon, B., Cottrell, C., Nagi, D., Page, E., Voigt, D., Courtney, H. C., Atkins, H., Higgins, K., Platts, J., Dhatariya, K., Patel, M., Newland‐Jones, P., Narendran, P., Kar, P., Burr, O., Thomas, S., Stewart, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Comorbidity COVID-19 COVID-19 - drug therapy COVID-19 - epidemiology Dexamethasone Dexamethasone - administration & dosage Dexamethasone - adverse effects Diabetes Diabetes mellitus Diabetes Mellitus - drug therapy Diabetes Mellitus - epidemiology Glucose Glucose monitoring Glycemic Control - methods Humans Hypoglycemia - chemically induced Hypoglycemia - prevention & control Insulin, Isophane - administration & dosage Letter Letters SARS-CoV-2 Steroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!